Is Covid-19 a cure for cancer? New study provides surprising insight

Four years ago, COVID-19 threw the world into crisis and put it into lockdown. It took many lives and left an indelible mark on the world’s healthcare. However, according to a new study, COVID-19 may also have some positive aspects.

Read this also Long Covid: new insights into symptoms, mechanisms and treatment prospects

There may actually be a huge potential benefit to COVID-19, according to a new study led by Justin Stebbing of Anglia Ruskin University. It can combat another deadly disease – cancer. The study says that Covid-19 can be an antidote to rapidly growing cancer cells and can help in reducing them.

Study findings:

The study focuses on the role that certain white blood cells, known as monocytes, play in defending the body against diseases and viruses. In cancer patients, monocytes can be hijacked by tumor cells and converted into cancer-friendly cells that also protect the tumor from the body’s immune system.

However, in severe COVID-19 infections, the body produces a special type of monocytes with anti-cancer properties. These monocytes have been developed specifically to target the COVID-19 virus, but they may also help fight cancer. Read this also One in 20 people suffer long-term effects of Covid-19: Study

To understand this, studies were conducted on mice with stage 4 cancer of different types of cancer such as melanoma, lung, breast and colon cancer. The mice were then given a drug that mimics the immune system’s response to severe COVID-19 infection. Unlike normal monocytes, these monocytes retained cancer-fighting properties and directly targeted the tumor. The results were remarkable as monocytes began to shrink tumors in all types of cancer.

What does this mean for cancer treatment?

This study may open new possibilities for cancer research and treatment. It also sheds light on the complex relationship between cancer cells and the body’s immune system. However, this does not mean that we should deliberately try to come into contact with the disease. Current immunotherapy practices focus mostly on T cells. However, this study opens a new avenue of cancer treatment. Read this also Are you at risk? New study reveals cancer risks hidden in your genes

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your doctor with any questions you may have about a medical condition.